Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Non-cash Items (2016 - 2018)

Amicus Therapeutics' Non-cash Items history spans 7 years, with the latest figure at $374444.0 for Q1 2018.

  • For the quarter ending Q1 2018, Non-cash Items fell 53.36% year-over-year to $374444.0, compared with a TTM value of $374444.0 through Mar 2018, down 53.36%, and an annual FY2017 reading of $105.8 million, up 1356310.26% over the prior year.
  • Non-cash Items for Q1 2018 was $374444.0 at Amicus Therapeutics, down from $105.8 million in the prior quarter.
  • The five-year high for Non-cash Items was $105.8 million in Q4 2017, with the low at $7800.0 in Q4 2016.
  • Average Non-cash Items over 5 years is $16.2 million, with a median of $5.8 million recorded in 2014.
  • Year-over-year, Non-cash Items crashed 98.52% in 2015 and then soared 1356310.26% in 2017.
  • Tracing FOLD's Non-cash Items over 5 years: stood at $5.4 million in 2014, then plummeted by 98.5% to $81900.0 in 2015, then crashed by 90.48% to $7800.0 in 2016, then soared by 1356310.26% to $105.8 million in 2017, then tumbled by 99.65% to $374444.0 in 2018.
  • Per Business Quant, the three most recent readings for FOLD's Non-cash Items are $374444.0 (Q1 2018), $105.8 million (Q4 2017), and $32.4 million (Q3 2017).